info@seagull-health.com
SeagullHealth
语言:
search
new
How much does Capivasertib cost per box?
502
Article source: Seagull Pharmacy
Jul 04, 2025

Capivasertib is a drug used to treat a specific type of breast cancer, and its price and purchase method have attracted much attention. This article will provide detailed information about Capivasertib from three aspects: price, purchase channel and pharmacological action, to help readers fully understand this drug.

How much does Capivasertib cost per box?

The price of Capivasertib varies depending on the specifications and manufacturers. The common Capivasertib generic drugs on the market are mainly produced by Lucius in Laos, and the price is relatively transparent.

Specifications and prices

Capivasertib produced by Lucius in Laos has two specifications: 160mg*64 tablets and 200mg*64 tablets. These prices may change due to market fluctuations or different purchase channels.

Factors affecting prices

The price of Capivasertib is affected by many factors, including production costs, market demand, and exchange rate fluctuations. In addition, since the drug has not yet been launched in China, domestic patients need to consider additional costs such as international transportation and tariffs when purchasing.

Knowing the price of Capivasertib can help patients make a good budget and avoid buying high-priced or counterfeit products due to information asymmetry.

How to buy Capivasertib

Since Capivasertib has not yet been launched in China, patients need to purchase it through formal channels to confirm the authenticity and safety of the drug.

Purchase channels

Patients can purchase Capivasertib through formal medical service institutions or international pharmacies. Choosing a qualified institution can reduce the risk of purchasing counterfeit or inferior drugs. When purchasing, be sure to verify the production date, packaging integrity and relevant certification documents of the drug.

Precautions

When purchasing Capivasertib, patients need to pay special attention to the authenticity of the drug. It is recommended to consult a doctor or professional pharmacist before purchasing to understand the detailed information and purchase recommendations of the drug. At the same time, keep the purchase receipt and related documents so that problems can be dealt with in time.

Purchasing Capivasertib through formal channels can not only maintain the quality of the drug, but also provide more safety protection for the patient's treatment.

What is the pharmacological effect of Capivasertib?

Capivasertib is a targeted therapy drug, mainly used to treat breast cancer patients with hormone receptor positive and HER2 negative. Its pharmacological mechanism of action is complex and precise.

Target of action

Capivasertib works by inhibiting the PIK3CA/AKT1/PTEN signaling pathway. This pathway plays a key role in the growth and survival of tumor cells, and inhibiting this pathway can effectively prevent the progression of tumors.

Therapeutic effect

Clinical studies have shown that Capivasertib combined with Fulvestine can significantly prolong the patient's progression-free survival. This drug is particularly suitable for breast cancer patients whose disease progresses after endocrine therapy, providing a new treatment option for such patients.

The pharmacological effect of Capivasertib makes it an important drug in the treatment of breast cancer, bringing more hope to patients. Understanding its mechanism of action can help patients better cooperate with treatment and improve efficacy.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Capivasertib(Truqap)
Capivasertib(Truqap)
Used in combination with fulvestrant for the treatment of HR-positive,...
WeChat Scan
Free Inquiry
Recommended Articles
Where to buy Capivasertib
Capivasertib is a potential targeted therapy that provides a new treatment option for patients with certain types of breast CA. Before using Capivasertib, patients usually need to undergo genetic...
Capivasertib instructions: indications, efficacy and effects, dosage, side effects, precautions
Capivasertib(Truqap) is a targeted therapy drug mainly used for patients with specific types of breast lesions. Its indications are based on genetic test results, and the applicable population mu...
Indications of Capivasertib
Capivasertib (also known as Truqap) is an innovative drug that is widely recognized internationally, especially in the treatment of specific types of breast diseases. However, its use is not with...
Precautions for futibatinib
Futibatinib, also known as LYTGOBI, is a new type of targeted therapy drug, mainly used to treat bile duct diseases. This article will explore the efficacy, dosage and precautions of futibatinib, aimi...
How effective is Capivasertib?
Capivasertib is a potential targeted therapy that provides a new treatment option for patients with specific types of breast CA. The drug has excellent therapeutic effects and is trusted by patie...
Side effects of Capivasertib(Truqap)
Capivasertib inhibits the activity of the PI3K/AKT signaling pathway, thereby controlling the proliferation and survival of diseased cells and delaying the progression of the disease. So, does Ca...
A brief introduction to Capivasertib
Capivasertib(Truqap) is a new type of targeted therapy for patients with specific types of advanced or metastatic breast lesions. The drug works by inhibiting the PI3K/AKT signaling pathway, prov...
Instructions for use and indications of Indian Capivasertib
Capivasertib(Truqap) is a targeted therapy for patients with specific breast lesions and should be used strictly in accordance with the doctor's instructions. Correct use of the drug can impr...
Related Articles
Side Effects of Capivasertib
Capivasertib is a next-generation AKT kinase inhibitor. Used in combination with fulvestrant, it treats HR-positive, HER2-negative advanced breast cancer harboring PIK3CA/AKT1/PTEN mutations. While de...
What Are the Precautions for Capivasertib Administration?
Capivasertib is a kinase inhibitor. It is used in combination with fulvestrant for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer harboring PIK3CA/AKT1/PTEN gene muta...
Dosage and Administration of Capivasertib
Capivasertib is a novel kinase inhibitor that received its first approval in the United States in 2023. As a precision therapy targeting specific gene mutations, it has demonstrated favorable efficacy...
What Are the Indications of Capivasertib?
Capivasertib is a kinase inhibitor developed by AstraZeneca, which was first approved for marketing in the United States in 2023. When used in combination with fulvestrant, this medication is indicate...
What Are the Purchase Channels for Capivasertib?
Capivasertib is an AKT kinase inhibitor, providing a new treatment option for patients with HR-positive, HER2-negative advanced breast cancer. As a prescription medication, understanding its standardi...
How to Use Capivasertib
Capivasertib is an AKT kinase inhibitor that was approved for marketing in the United States in 2023. It is indicated for the treatment of locally advanced or metastatic breast cancer that is hormone ...
How to Use Capivasertib
Capivasertib is an AKT kinase inhibitor that was approved for marketing in the United States in 2023. It is indicated for the treatment of locally advanced or metastatic breast cancer that is hormone ...
What Are the Side Effects of Capivasertib?
Capivasertib, when used in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative,...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved